Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$77.8M |
| 2 |
Zoom
ZM
|
+$65.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$56.4M |
| 4 |
Peloton Interactive
PTON
|
+$56.1M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$189M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
PPLI
People Inc
PPLI
|
+$80.9M |
| 4 |
Amazon
AMZN
|
+$73.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$54.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.37% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Northwest Bancshares
NWBI
$2.31B
| $2.53M | ﹤0.01% |
274,700
+4,600
| +2% | +$45.4K |
|
1602
SITE Centers
SITC
$156M
| $2.52M | ﹤0.01% |
448,869
+5,255
| +1% | +$31.1K |
|
1603
Helios Technologies
HLIO
$2.66B
| $2.52M | ﹤0.01% |
69,100
+1,100
| +2% | +$42.6K |
|
1604
Strategy Inc
MSTR
$38.2B
| $2.51M | ﹤0.01% |
167,000
-13,000
| -7% | -$176K |
|
|
CVGW
1605
DELISTED
Calavo Growers
CVGW
| $2.51M | ﹤0.01% |
37,900
+600
| +2% | +$37.7K |
|
1606
AMERISAFE
AMSF
$517M
| $2.51M | ﹤0.01% |
43,700
+600
| +1% | +$37.8K |
|
1607
ATI
ATI
$31.4B
| $2.5M | ﹤0.01% |
287,000
+5,500
| +2% | +$50.6K |
|
1608
Astec Industries
ASTE
$994M
| $2.5M | ﹤0.01% |
46,100
+800
| +2% | +$40K |
|
1609
Independence Realty Trust
IRT
$3.96B
| $2.49M | ﹤0.01% |
214,700
-14,200
| -6% | -$163K |
|
1610
Enpro
NPO
$7.12B
| $2.49M | ﹤0.01% |
44,100
| – | – |
|
1611
Enviri
NVRI
$583M
| $2.49M | ﹤0.01% |
178,800
+3,600
| +2% | +$52K |
|
|
NGD
1612
DELISTED
New Gold Inc
NGD
| $2.48M | ﹤0.01% |
1,463,662
+25,600
| +2% | +$41.1K |
|
1613
Supernus Pharmaceuticals
SUPN
$2.78B
| $2.48M | ﹤0.01% |
119,100
+2,000
| +2% | +$45.4K |
|
|
ICPT
1614
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.48M | ﹤0.01% |
59,700
+1,000
| +2% | +$45.9K |
|
|
HOUS
1615
DELISTED
Anywhere Real Estate
HOUS
| $2.47M | ﹤0.01% |
261,500
+6,200
| +2% | +$59.5K |
|
1616
Alamo Group
ALG
$2.01B
| $2.46M | ﹤0.01% |
22,800
+300
| +1% | +$31.9K |
|
|
GLUU
1617
DELISTED
Glu Mobile Inc.
GLUU
| $2.46M | ﹤0.01% |
320,900
+4,900
| +2% | +$41.2K |
|
1618
Middlesex Water
MSEX
$1.1B
| $2.46M | ﹤0.01% |
39,562
+700
| +2% | +$45.4K |
|
1619
Encore Capital Group
ECPG
$2.07B
| $2.46M | ﹤0.01% |
63,700
+1,200
| +2% | +$47.9K |
|
|
FARO
1620
DELISTED
Faro Technologies
FARO
| $2.45M | ﹤0.01% |
40,200
+900
| +2% | +$51.6K |
|
|
AXNX
1621
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.45M | ﹤0.01% |
48,000
+700
| +1% | +$29.2K |
|
1622
Stride
LRN
$3.27B
| $2.45M | ﹤0.01% |
92,900
+1,400
| +2% | +$54.1K |
|
|
CADE
1623
DELISTED
Cadence Bancorporation
CADE
| $2.45M | ﹤0.01% |
284,805
| – | – |
|
1624
Deluxe
DLX
$1.09B
| $2.44M | ﹤0.01% |
94,800
+600
| +0.6% | +$15.5K |
|
|
AGNT
1625
AGNT Inc
AGNT
$715M
| $2.44M | ﹤0.01% |
120,800
+5,400
| +5% | +$83.2K |
|
Similar funds
Swiss National Bank's Q3 2020 Portfolio in Review
As of Q3 2020, Swiss National Bank held 2,445 positions worth $128B, up 8.1% from $118B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 0.9%. Swiss National Bank opened 7 new positions and exited 15, leaving the 2,445-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2020 buy was Peloton Interactive: 762,000 shares worth $75.6M.
- Swiss National Bank added most to Match Group in Q3 2020, an estimated $77.8M increase.
- Swiss National Bank's biggest Q3 2020 reduction was Apple, cutting an estimated $189M.
- Swiss National Bank fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $14.8M.
- Swiss National Bank's ten largest holdings make up 24% of its $128B portfolio in Q3 2020.
- Swiss National Bank opened 7 new positions and closed 15 in Q3 2020.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $128B.
Based on Swiss National Bank's 13F filing for Q3 2020, filed 9 Nov 2020.